Exilby has just been approved in Germany and Austria for chronic low back pain and serial entrepreneur Clemens Fischer tells Scrip the German-based group can turn the cannabis-derived drug into a blockbuster on its own.
Exilby has just been approved in Germany and Austria for chronic low back pain and serial entrepreneur Clemens Fischer tells Scrip the German-based group can turn the cannabis-derived drug into a blockbuster on its own.